An efficient system was developed for the co-expression of a yeast tRNATyr/tyrosyl-tRNA synthetase (TyrRS) pair in Escherichia coli. Analysis of suppression patterns using several sets of E. coli and phage mutants indicated that the expressed yeast suppressor tRNATyr was aminoacylated only with tyrosine by its cognate yeast TyrRS and not by E. coli TyrRS or other aminoacyl-tRNA synthetases. This extra tRNA/TyrRS pair is expected to be a key bridgehead for developing an in vivo system for the site-directed incorporation of unnatural amino acids into proteins.
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Recently, it became possible to incorporate non-canonical (i.e., not specified in the genetic code) amino acids into proteins site-specifically in a cell-free translation system (1) . This method involves chemically aminoacylated sup pressor tRNAs, which incorporate the non-canonical amino acid into the programmed "stop" codons. Although a large number of novel amino acids have already been successfully introduced into "alloproteins" (2-5), the usefulness of this system seems to be rather limited because it requires many steps of laborious biochemical treatment and the final yields of the alloproteins are typically not enough for sample-intensive methods such as NMR spectroscopy. Therefore, the development of an in vivo approach for the site-specific incorporation of non-canonical amino acids into proteins could potentially enhance the value of this tech nique. Such a system would require at least two trans lational apparatus components: (i) a suppressor tRNA that is charged with the novel amino acid but is not a substrate for any other endogenous aminoacyl-tRNA synthetases, and (ii) an aminoacyl-tRNA synthetase with substrate specificity for the suppressor tRNA and for the novel amino acid. Very recently, several groups described a strategy for or the results of trials to establish such suppressor tRNA/ aminoacyl-tRNA synthetase pairs that are functional in vivo (6-8).
We considered that a yeast tRNATyr/TyrRS pair, when introduced into Escherichia coli cells, would be an ideal candidate for this purpose for the following reasons. (i) Yeast tRNATyr has a unique identity element, i.e., a Cl-G72 base pair at the end of the acceptor stem, which is not found in E, coli tRNAs except for tRNAPrO (9 As shown in Table II (lacam1000 column), no transformant derived from 1000BT grew as blue colonies on LB-amp -X-Gal plates. This means that the suppression of an amber codon is not due to the incorporation of Gin or Trp. Moreover, only the BT3 cells transformed with pMWSup-YRS could grow on minimal media plates (Table II; metam3 column). This indicates that Tyr, Gln, or Trp was incorpo rated at the amber codon. These results together strongly suggest that the amber suppression in these cases is due to the incorporation of tyrosine, and that the amber suppres sor tRNA and TyrRS from yeast can function as an extra pair in E. coli cells. codon is suppressed by Su +3 (12), these results unam biguously indicate that the, co-expressed amber suppressor tRNA and TyrRS pair suppressed the amber codon by inserting tyrosine. In other words, the amber UAG colon in this situation is assigned to an "extra" tyrosine specifically decoded by the extra amber suppressor tRNA/TyrRS pair transplanted from yeast into E. coli cells. This means that once a TyrRS mutant with specificity to non-canonical amino acids is obtained, this co-expression system will be applicable to the site-directed incorporation of non-cano nical amino acids into proteins in vivo. We have already obtained several TyrRS mutants with altered amino acid specificities by genetic engineering (Ohno et al., manu script in preparation), and construction of the in vivo system is underway.
As already mentioned, several research groups recently described a strategy for or the results of trials to establish such tRNA/aminoacyl-tRNA synthetase pairs that are functional in vivo (6-8). We think our system has some advantages compared to them. First, the strictness of the decoding specificity of our system is excellent since neither the suppressor tRNA nor TyrRS expressed alone seems to affect the endogenous protein synthesis in E. coli ( Fig. 2 and Table II ). As the host cells transformed with pMWYRS could grow without any apparent problem (Fig. 2) , the expressed yeast TyrRS seems to be unable to recognize endogenous E. coli tRNAs. In addition, the suppressor tRNA alone does not seem to be charged with any amino acids in E. coli cells (Table I, CA274 [pMWSup] row; Table  II , suppressor tRNA row). Although Perret et al. (13) reported that E. coli tRNATyr was efficiently charged by yeast TyrRS (their unpublished results), we think their result is questionable. We could not aminoacylate E. coli tRNATYr with yeast TyrRS in our in vitro experiments, and Chow and RajBhandary (9) have reported that yeast TyrRS strongly recognizes the C1-G72 base pair which is present in yeast tRNATYr but not in E. coli tRNATYF. There remains a possibility that a low level of proline was actually incorpo rated by the yeast suppressor tRNA/TyrRS system since the C1-G72 base pair was found to be a part of the identity determinant for E. coli prolyl-tRNA synthetase (14, 15). However, we could not detect any charging of proline to yeast tRNATYr by E. coli prolyl-tRNA synthetase, at least under the in vitro reaction conditions so far tested (data not shown). Taking all the above into consideration, the amber UAG codon in our system will have very low chance of suffering from "double-meaning" as to amino acid assign ment as it does in other systems (6-8). This will help increase the homogeneity of amber-mutated target pro teins. Second, the coding sequence of yeast TyrRS is readily changeable in our system. Since the TyrRS gene is inserted into the site between Notl and Sphl, and these restriction sites exist only once in pMWSupYRS (Fig. 1d) , the coding sequence of a mutant TyrRS with the desired amino acid specificity can be easily substituted for that of wild-type TyrRS, like a cassette. Third, since the replica tion origin of pMWSupYRS is different from that of usual expression vectors commercially available, one more plasmid can be co-transfected simultaneously to supply the mRNA for the synthesis of the target protein. We believe that our system will be one of the best systems currently available for the site-directed incorporation of non-cano nical amino acids into proteins in vivo.
